Study Participant Receives NIAID/GSK Candidate Ebola Vaccine
Image by NIAID
September 2, 2014 — A 39-year-old woman, the first participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Md. Credit: NIAID
A ferocious storm dumped massive piles of snow on parts of upstate New York, trapping residents in their homes and stranding motorists on roadways, as temperatures in all 50 states fell to freezing or below. Even hardened Buffalo residents were caught off-guard Tuesday as more than 4 feet fell in parts of the city.
MyFox Washington DC – Home